Target & Activity
| Target | Activity | Value |
|---|---|---|
| Human Endogenous Metabolite |
Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| A549 | IC50 | > 100 μM | Cytotoxicity against human A549 cells after 72 hrs by MTT assay | [PMID: 21696954] |
| A549 | IC50 | 21.11 μM | Antiproliferative activity against human A549 cells after 48 hrs by MTT assay | [PMID: 28720504] |
| BT-549 | IC50 | 1 mM | Antiproliferative activity against human BT549 cells after 24 hrs by MTT assay | [PMID: 29144746] |
| HCT-116 | IC50 | 8.05 μM | Cytotoxicity against human HCT116 cells after 96 hrs by MTT assay | [PMID: 23746477] |
| HEK-293T | IC50 | 189.63 μM | Antiproliferative activity against human 293T cells after 48 hrs by MTT assay | [PMID: 28720504] |
| HeLa | IC50 | 42.35 μM | Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay | [PMID: 28720504] |
| HT-29 | IC50 | 22.67 μM | Antiproliferative activity against human HT-29 cells after 48 hrs by MTT assay | [PMID: 28720504] |
| HT-29 | IC50 | 4.35 μM | Cytotoxicity against human HT-29 cells after 96 hrs by MTT assay | [PMID: 23746477] |
| LNCaP | IC50 | > 20 μg/mL | Inhibitory activity against 5-alpha-reductase type 1 in cell culture system using LNCaP cells (androgen-sensitive human prostatic cancer cell line) | [PMID: 11527731] |
| LoVo | IC50 | 97 μM | Cytotoxicity against human LoVo cells after 72 hrs by MTT assay | [PMID: 21696954] |
| MCF7 | IC50 | 2.9 μM | Antiproliferative activity against human MCF7 cells after 24 hrs by MTT assay | [PMID: 29144746] |
| MDA-MB-231 | IC50 | 3.7 μM | Antiproliferative activity against human MDA-MB-231 cells after 24 hrs by MTT assay | [PMID: 29144746] |
| MT4 | IC50 | 2341 μM | Cytotoxicity against human MT4 cells after 96 hrs by MTT assay | [PMID: 23746477] |
| PC-3 | IC50 | > 100 μM | Cytotoxicity against human PC3 cells after 72 hrs by MTT assay | [PMID: 21696954] |
| SK-MEL-28 | IC50 | > 100 μM | Cytotoxicity against human SK-MEL-28 cells after 72 hrs by MTT assay | [PMID: 21696954] |
| SK-MEL-28 | IC50 | 0.48 μM | Anticancer activity against human SK-MEL-28 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay | [PMID: 37197457] |
| SK-MEL3 | IC50 | 1.6 μM | Anticancer activity against human SK-MEL3 cells assessed as reduction in cell viability incubated for 24 hrs in presence of Artesunic acid by MTT assay | [PMID: 37197457] |
| SK-MEL3 | IC50 | 2.1 μM | Anticancer activity against human SK-MEL3 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay | [PMID: 37197457] |
| SMMC-7721 | IC50 | 19.9 μM | Antiproliferative activity against human SMMC7721 cells after 48 hrs by MTT assay | [PMID: 28720504] |
| U-373MG ATCC | IC50 | > 100 μM | Cytotoxicity against human U373 cells after 72 hrs by MTT assay | [PMID: 21696954] |
20 records · Scroll to view more